Peptides extracted from seaweed proteins show promise for lowering blood pressure, fighting diabetes, and reducing oxidative stress, though most evidence is still from lab studies.
ACE inhibition confirmedMultiple seaweed species yield peptides that block the angiotensin-converting enzyme involved in high blood pressure
What the researchers found
Peptides isolated from seaweed proteins have demonstrated ACE-inhibiting (blood pressure-lowering), antioxidant, and antidiabetic activities in laboratory studies. Multiple seaweed species have yielded bioactive peptides through enzymatic hydrolysis that could serve as functional food ingredients or drug candidates for cardiovascular disease and diabetes prevention. However, most evidence comes from in vitro studies, and large-scale production, in vivo validation, and safety testing are still needed.
Why it matters
Cardiovascular disease and diabetes are the leading causes of death globally. Finding new peptide-based treatments from sustainable sources like seaweed could provide affordable, food-derived therapeutic options. Seaweed is abundant, renewable, and already part of many diets worldwide, making it an attractive platform for bioactive peptide production.
How the study worked
This is a review article summarizing recent research on the production, isolation, and health effects of bioactive peptides derived from seaweed proteins. The authors surveyed published studies on ACE inhibition, antihypertensive, antioxidant, and antidiabetic properties of these peptides.
Who was studied
Not applicable (review article covering laboratory and preclinical research)
What this study cannot tell us
Most studies reviewed were conducted in laboratory settings (in vitro), with limited in vivo or human clinical data. Large-scale production methods haven't been established. Peptide stability during digestion, interactions with other drugs or foods, and long-term safety are still unknown.
How to read the evidence
This is a review of primarily in vitro (laboratory) research. While it provides a useful overview, the lack of human clinical data means the health claims remain preliminary.
When this study was published
Published in 2018. Seaweed peptide research has continued to advance, with more in vivo studies emerging since this review, though human clinical trials remain limited.
The bigger picture
The search for bioactive peptides from food sources is a growing field in nutraceutical and pharmaceutical research. Seaweed is particularly interesting because it's sustainable, widely available, and rich in unique proteins not found in land-based plants. If seaweed peptides can be validated in human studies, they could become a new category of functional food ingredients for preventing the world's two leading killers.
Questions still open
- Do seaweed-derived peptides survive human digestion intact enough to exert their bioactive effects?
- Which specific seaweed species produce the most potent blood pressure-lowering peptides?
- Could seaweed peptide supplements be as effective as existing ACE inhibitor medications?
Common questions
Can eating seaweed lower blood pressure?
Are seaweed peptide supplements available?
Read the original research
Bioactive Peptides Derived from Seaweed Protein and Their Health Benefits: Antihypertensive, Antioxidant, and Antidiabetic Properties.
Journal of food science, 83(1), 6-16
Citation
Admassu, Habtamu; Gasmalla, Mohammed Abdalbasit A; Yang, Ruijin; Zhao, Wei. (2018). Bioactive Peptides Derived from Seaweed Protein and Their Health Benefits: Antihypertensive, Antioxidant, and Antidiabetic Properties.. Journal of food science, 83(1), 6-16. https://doi.org/10.1111/1750-3841.14011